SynaptixBio
Oxford, United Kingdom· Est.
SynaptixBio is a rare disease biotech pioneering ground-breaking development for treatment of severe leukodystrophies which affect the brain. SynaptixBio will tackle a specific acute subset of leukodystrophies by altering the expression of a mutated gene identified as causing the disease.
Private Company
Total funding raised: $1.7M
About
SynaptixBio is a rare disease biotech pioneering ground-breaking development for treatment of severe leukodystrophies which affect the brain. SynaptixBio will tackle a specific acute subset of leukodystrophies by altering the expression of a mutated gene identified as causing the disease.
RNA & Gene Therapy
Funding History
2Total raised:$1.7M
Grant$500K
Seed$1.2M